Genomics in general practice

Reproductive carrier screening
☰ Table of contents

Practice point

All women or couples planning a pregnancy, or who are already pregnant, should have a comprehensive family history recorded.1

Women or couples who are known carriers of a genetic condition or have a relevant family history should be made aware of the availability of carrier screening and offered referral to specialist services (ie genetics or obstetrics).1

Carrier screening for common recessive genetic conditions (eg cystic fibrosis [CF]) may be offered to low-risk women or couples (ie regardless of family history and ethnicity).

The decision to have screening is a personal choice to be made by the individual or couple.


What do I need to know?

Carrier screening is used to identify carriers of genetic conditions with an Autosomal recessive inheritance pattern.
Carrier screening can be offered to all women or couples during pre-conception and early in the pregnancy (ie first trimester). Identifying carrier couples before pregnancy provides greater reproductive options.

For example:

Traditionally, carrier screening for inherited recessive conditions was offered on the basis of ethnicity. However, given the multicultural nature of society and marriage between people of different ethnic backgrounds, ethnicity is less strongly predictive of carrier frequency in Australia. Therefore, carrier screening panels increasingly test for multiple conditions, irrespective of ethnicity.2

The decision to undertake carrier screening is a personal choice to be made by the individual or couple. Women or couples should be informed of the benefits, limitations and cost of screening. Ideally, this information is provided pre-pregnancy.1


Genetic testing

A number of pathology services offer carrier screening, which can be ordered through general practice. However, carrier screening is not available through the Medicare Benefits Schedule (MBS). Depending on the test provider:

  • screening may look for a limited number of conditions (eg CF, Fragile X syndrome [FXS], spinal muscular atrophy) or screen for an expanded range of conditions (ie >100)
  • genetic counselling may or may not be available.

Note: Carriers of haemoglobinopathies may be initially identified through a routine full blood examination (FBE).


When should I refer?

Couples identified as carriers of a genetic condition should be offered referral to specialist services (ie genetics or obstetrics).


Other considerations

Carrier screening needs to occur in a timely manner to provide women or couples with reproductive options. The testing of biological male partners of pregnant female carriers is of particular importance.


Resources for general practitioners

Henneman L, Borry P, Chokoshvili D, et al. Responsible implementation of expanded carrier screening. Eur J Hum Genet 2016;24(6):e1–e12.
The Royal Australian College of General Practitioners, Guidelines for preventive activities in general practice


Resources for patients


Cystic Fibrosis Community Care, Cystic fibrosis carrier screening


Spinal Muscular Atrophy (SMA) Australia
The Fragile X Association of Australia

Genomics in general practice



  1. The Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Prenatal screening and diagnosis of chromosomal and genetic conditions in the fetus in pregnancy (C-Obs 59). Melbourne: RANZCOG, 2015. [Accessed 8 January 2018].
  2. American College of Obstetricians and Gynecologists. Committee Opinion no. 690: Carrier screening in the age of genomic medicine. Obstet Gynecol 2017;129(3):e35–40. [Accessed 8 January 2018].


Genomics in general practice (PDF 3.1 MB)